Josef Melcr

Josef Melcr is a co-founder of Protyon, a Netherlands-based company dedicated to pioneering personalized cancer therapies through computational modeling and predictive analytics. As Chief Product & Tech Officer, he contributes to a team of experts with extensive scientific backgrounds in computational modeling. Melcr's expertise lies in leveraging technology to develop data-driven solutions for enhanced treatment efficacy and improved patient outcomes in oncology.